The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease
Open accessAbstract
Thyroid-stimulating hormone receptor (TSHR) plays a central role in regulating thyroid function and is targeted by IgGs in Graves’ disease (GD-IgG). Whether TSHR is involved in the pathogenesis of thyroid-associated ophthalmopathy (TAO), the orbital manifestation of GD, remains uncertain. TSHR signaling overlaps with that of insulin-like grow factor 1 receptor (IGF-1R). GD-IgG can activate fibroblasts derived from donors with GD to synthesize T cell chemoattractants and hyaluronan, actions mediated through IGF-1R. In this study, we compare levels of IGF-1R and TSHR on the surfaces of TAO and control orbital fibroblasts and thyrocytes and explore the physical and functional relationship between the two receptors. TSHR levels are 11-fold higher on thyrocytes than on TAO or control fibroblasts. In contrast, IGF-1R levels are 3-fold higher on TAO vs control fibroblasts. In pull-down studies using fibroblasts, thyrocytes, and thyroid tissue, Abs directed specifically against either IGF-1Rβ or TSHR bring both proteins out of solution. Moreover, IGF-1Rβ and TSHR colocalize to the perinuclear and cytoplasmic compartments in fibroblasts and thyrocytes by confocal microscopy. Examination of orbital tissue from patients with TAO reveals similar colocalization to cell membranes. Treatment of primary thyrocytes with recombinant human TSH results in rapid ERK phosphorylation which can be blocked by an IGF-1R-blocking mAb. Our findings suggest that IGF-1R might mediate some TSH-provoked signaling. Furthermore, they indicate that TSHR levels on orbital fibroblasts are considerably lower than those on thyrocytes and that this receptor associates with IGF-1R in situ and together may comprise a functional complex in thyroid and orbital tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Werner & Ingbar's the thyroid : a fundamental and clinical text
Werner, S. C., Ingbar, S. H., Braverman, L. E., & Utiger, R. D. (2012) · Lippincott-Raven eBooks · Cited by 1,016
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Structure and function of the type 1 insulin-like growth factor receptor
Adams, T. E., Epa, V. C., Garrett, T. P. J., & Ward*, C. W. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000744 · Cited by 630
Structural biology of insulin and IGF1 receptors: implications for drug design
De Meyts, P., & Whittaker, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd917 · Cited by 582
Szkudlinski, M. W., Fremont, V., Ronin, C., & Weintraub, B. D. (2002) · Physiological Reviews · doi:10.1152/physrev.00031.2001 · Cited by 458
Kent, S. C., Chen, Y., Bregoli, L., Clemmings, S. M., Kenyon, N. S., Ricordi, C., Hering, B. J., & Hafler, D. A. (2005) · Nature · doi:10.1038/nature03625 · Cited by 409
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
Gerding, M. N., van der Meer, J. W. C., Broenink, M., Bakker, O., Wiersinga, W. M., & Prummel, M. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00959.x · Cited by 325
Pritchard, J., Han, R., Horst, N., Cruikshank, W. W., & Smith, T. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6348 · Cited by 295
Self-citationTRAMONTANO, D., CUSHING, G. W., MOSES, A. C., & INGBAR, S. H. (1986) · Endocrinology · doi:10.1210/endo-119-2-940 · Cited by 293
Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue
Feliciello, A., Ciullo, I., Fenzi, G. F., Bonavolontà, G., Porcellini, A., & Avvedimento, E. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91475-2 · Cited by 288
Smith, T. J., & Hoa, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0716 · Cited by 256
Self-citationVecchione, A., Marchese, A., Henry, P., Rotin, D., & Morrione, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3363-3372.2003 · Cited by 251
Wakelkamp, I. M. M. J., Bakker, O., Baldeschi, L., Wiersinga, W. M., & Prummel, M. F. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01708.x · Cited by 221
Antiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214
Key Apoptotic Pathways for Heat-Induced Programmed Germ Cell Death in the Testis
Hikim, A. P. S., Lue, Y., Yamamoto, C. M., Vera, Y., Rodriguez, S., Yen, P. H., Soeng, K., Wang, C., & Swerdloff, R. S. (2003) · Endocrinology · doi:10.1210/en.2003-0175 · Cited by 213
Luttrell, L. M., van Biesen, T., Hawes, B. E., Koch, W. J., Touhara, K., & Lefkowitz, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16495 · Cited by 199
Agonist-independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2 Receptors
Lee, D. K., Lança, A. J., Cheng, R., Nguyen, T., Ji, X. D., Gobeil, F., Chemtob, S., George, S. R., & O'Dowd, B. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306377200 · Cited by 190
Insulin-like growth factor-I regulates pro-B cell differentiation
Landreth, K., Narayanan, R., & Dorshkind, K. (1992) · Blood · doi:10.1182/blood.v80.5.1207.1207 · Cited by 188
Valyasevi, R. W., Erickson, D. Z., Harteneck, D. A., Dutton, C. M., Heufelder, A. E., Jyonouchi, S. C., & Bahn, R. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5838 · Cited by 172
Robinson, E., Keystone, E. C., Schall, T. J., Gillett, N., & Fish, E. N. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03126.x · Cited by 160
Douglas, R. S., Gianoukakis, A. G., Kamat, S., & Smith, T. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3281 · Cited by 157
Self-citationRosenfeld, R. G., & Dollar, L. A. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-3-434 · Cited by 154
Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts
Bell, A., Gagnon, A., Grunder, L., Parikh, S. J., Smith, T. J., & Sorisky, A. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.2.c335 · Cited by 138
Self-citationTramontano, D., Moses, A. C., Veneziani, B. M., & Ingbar, S. H. (1988) · Endocrinology · doi:10.1210/endo-122-1-127 · Cited by 137
Insights Into the Pathogenesis of Thyroid-Associated Orbitopathy
Kazim, M. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.380 · Cited by 135
Thyrotropin Receptor Transcripts in Human Adipose Tissue
Crisp, M., Lane, C., Halliwell, M., Wynford‐Thomas, D., & Ludgate, M. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.2003 · Cited by 134
Cloning and Functional Expression of a Thyrotropin Receptor cDNA from Rat Fat Cells
Endo, T., Ohta, K., Haraguchi, K., & Onaya, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10833 · Cited by 126
Bonifacio, E. E., Scirpoli, M., Kredel, K., Füchtenbusch, M., & Ziegler, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.525 · Cited by 124
Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts
Smith, T. J., Sempowski, G. D., Wang, H. S., Vecchio, P. J. D., Lippe, S. D., & Phipps, R. P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2620 · Cited by 123
Self-citationFranz, J. K., Kolb, S., Hummel, K. M., Lahrtz, F., Neidhart, M., Aicher, W. K., Pap, T., Gay, R. E., Fontana, A., & Gay, S. (1998) · European Journal of Immunology · Cited by 115
Posttranslational Modifications of Self‐Antigens
Doyle, H. A., & Mamula, M. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.001 · Cited by 109
Dupont, J., Fernandez, A. M., Glackin, C. A., Helman, L. J., & LeRoith, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102664200 · Cited by 107
Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I.
Binz, K., Joller, P. W., Froesch, P., Binz, H., Zapf, J., & Froesch, E. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3690 · Cited by 106
Adipogenesis in thyroid eye disease.
Crisp, M., Starkey, K. J., Lane, C., Ham, J., & Ludgate, M. (2000) · PubMed · Cited by 102
Starkey, K., Janezić, A., Jones, G., et al. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300369 · Cited by 90
El‐Shewy, H. M., Johnson, K. R., Lee, M., Jaffa, A. A., Obeid, L. M., & Luttrell, L. M. (2006) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84052-8 · Cited by 89
Paschke, R., Vassart, G., & Ludgate, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02681.x · Cited by 87
Suh, J. M., Song, J. H., Kim, D. W., Kim, H., Chung, H. K., Hwang, J. H., Kim, J., Hwang, E. S., Chung, J., Han, J.-H., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300805200 · Cited by 84
Valyasevi, R. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2557 · Cited by 82
Smith, T. J., Ahmed, A. A., Hogg, M. G., & Higgins, P. J. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.1.c24 · Cited by 77
Self-citationDifferential Effects of Cyclic Adenosine 3',5'-Monophosphate on p70 Ribosomal S6 Kinase
Cass, L. A., & Meinkoth, J. L. (1998) · Endocrinology · doi:10.1210/endo.139.4.5880 · Cited by 76
Internalization and Recycling Pathways of the Thyrotropin Receptor
Baratti-Elbaz, C., Ghinea, N., Lahuna, O., Loosfelt, H., Pichon, C., & Milgröm, E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.10.0360 · Cited by 75
Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes
Davies, T. F., TENG, C. S., McLachlan, S. M., Smith, B. R., & Hall, R. (1978) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(78)90072-2 · Cited by 74
Thyrotropin Receptor in Non-thyroid Tissues
Endo, T., Ohno, M., Kotani, S., Gunji, K., & Onaya, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1116 · Cited by 68
Park, E. S., Kim, H., Suh, J. M., Park, S. J., You, S. H., Chung, H. K., Lee, K. W., Kwon, O., Cho, B. Y., Kim, Y. K., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.5.662 · Cited by 62
Agretti, P., Chiovato, L., Marco, G. D., Marcocci, C., Mazzi, B., Sellari‐Franceschini, S., Vitti, P., Pinchera, A., & Tonacchera, M. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470733 · Cited by 52
Kooijman, R., Scholtens, L. E., Rijkers, G. T., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250411 · Cited by 48
Thyrotropin Induces SOCS-1 (Suppressor of Cytokine Signaling-1) and SOCS-3 in FRTL-5 Thyroid Cells
Park, E. S., Kim, H., Suh, J. M., Park, S. J., Kwon, O., Kim, Y. K., Ro, H. K., Cho, B. Y., Chung, J., & Shong, M. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.3.0433 · Cited by 46
Li, S., Kato, J., Paz, I. B., Kasuya, J., & Fujita‐Yamaguchi, Y. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2220 · Cited by 44
Feracci, H., Bernadac, A., Hovs�pian, S., Fayet, G., & MAROUX, S. (1981) · Cell and Tissue Research · doi:10.1007/bf00216576 · Cited by 43
Agretti, P., Marco, G. D., Servi, M. D., Marcocci, C., Vitti, P., Pinchera, A., & Tonacchera, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01900 · Cited by 43
Tramontano, D., Moses, A. C., & Ingbar, S. H. (1988) · Endocrinology · doi:10.1210/endo-122-1-133 · Cited by 41
Effects of Thyrotropin on the Proliferation and Differentiation of Cultured Rat Preadipocytes
Haraguchi, K., Shimura, H., KAWAGUCHI, A., Ikeda, M., Endo, T., & Onaya, T. (1999) · Thyroid · doi:10.1089/thy.1999.9.613 · Cited by 34
Chen, C.-W., & Roy, D. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03751-3 · Cited by 22
Prostaglandin endoperoxide H synthase expression in human thyroid epithelial cells
Gianoukakis, A. G., Cao, H., Jennings, T. A., & Smith, T. J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c701 · Cited by 20
Self-citation
Cited by
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Smith, T. J., & Hegedüs, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510030 · Cited by 1,257
Self-citationBartalena, L., Kahaly, G. J., Baldeschi, L., Dayan, C. M., Eckstein, A., Marcocci, C., Marinò, M., Vaidya, B., Wiersinga, W. M., _, _., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0479 · Cited by 1,054
Teprotumumab for Thyroid-Associated Ophthalmopathy
Smith, T. J., Kahaly, G. J., Ezra, D. G., Fleming, J. C., Dailey, R. A., Tang, R. A., Harris, G. J., Antonelli, A., Salvi, M., Goldberg, R. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614949 · Cited by 756
Self-citationTeprotumumab for the Treatment of Active Thyroid Eye Disease
Douglas, R. S., Kahaly, G. J., Patel, A., Sile, S., Thompson, E. H. Z., Perdok, R., Fleming, J. C., Fowler, B. T., Marcocci, C., Marinò, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910434 · Cited by 752
Self-citation
Metadata
- Authors
- Tsui, S., Naik, V., Hoa, N., Hwang, C. J., Afifiyan, N. F., Sinha Hikim, A., Gianoukakis, A. G., Douglas, R. S., & Smith, T. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09
- Volume
- 181
- Issue
- 6
- Pages
- 4397-4405
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2151135812
- Cited by
- 372
- References
- 57
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.